Post completion of this purchase of shares, the total holding of the wholly-owned subsidiary company was increased from 96.96% to 100% in PJSC Biosintez, the pharma company said in the filing.
from India Infoline News Service https://ift.tt/2Na2JIj
No comments:
Post a Comment